Fitness-balanced escape determines resolution of dynamic founder virus escape processes in HIV-1 infection

Journal of Virology

Volumn 89, Issue 20, 2015, Pages 10303-10318

  Sunshine, Justine E ^a   Larsen, Brendan B ^b   Maust, Brandon ^b   Casey, Ellie ^b   Deng, Wenje ^b   Chen, Lennie ^b   Westfall, Dylan H ^b   Kim, Moon ^b   Zhao, Hong ^b   Ghorai, Suvankar ^b   Lanxon Cookson, Erinn ^b   Rolland, Morgane ^c,d   Collier, Ann C ^b   Maenza, Janine ^b   Mullins, James I ^b   Frahm, Nicole ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c US Military HIV Research Program   (United States)

^d HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; PROTEIN P17;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PYROSEQUENCING; SEQUENCE ANALYSIS; VIRUS CELL INTERACTION; VIRUS IDENTIFICATION; VIRUS TRANSMISSION; AMINO ACID SEQUENCE; CHEMISTRY; DRUG EFFECTS; ENTROPY; FOUNDER EFFECT; GENETIC SELECTION; GENETICS; HIGH THROUGHPUT SEQUENCING; HIV SEROPOSITIVITY; HUMAN; IMMUNE EVASION; IMMUNOLOGY; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PRIMARY CELL CULTURE; REPRODUCTIVE FITNESS; TRANSMISSION; VIROLOGY; VIRUS LOAD;

AMINO ACID SEQUENCE; BASE SEQUENCE; ENTROPY; EPITOPES, T-LYMPHOCYTE; FOUNDER EFFECT; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENETIC FITNESS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNE EVASION; INTERFERON-GAMMA; INTERLEUKIN-2; MOLECULAR SEQUENCE DATA; MUTATION; PRIMARY CELL CULTURE; SELECTION, GENETIC; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 84942133739     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01876-15     Document Type: Article

References (69)

1. Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI. 1994. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 68:6672-6683.
2. Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Brown AJ, Simmonds P. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 67:3345-3356.
3. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179-1181. http://dx.doi.org/10.1126/science.8356453.
4. Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, Athreya GS, Treurnicht FK, Keele BF, Wood N, Salazar-Gonzalez JF, Bhattacharya T, Chu H, Hoffman I, Galvin S, Mapanje C, Kazembe P, Thebus R, Fiscus S, Hide W, Cohen MS, Karim SA, Haynes BF, Shaw GM, Hahn BH, Korber BT, Swanstrom R, Williamson C. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J Virol 83:3556-3567. http://dx.doi.org/10.1128/JVI.02132-08.
5. Herbeck JT, Rolland M, Liu Y, McLaughlin S, McNevin J, Zhao H, Wong K, Stoddard JN, Raugi D, Sorensen S, Genowati I, Birditt B, McKay A, Diem K, Maust BS, Deng W, Collier AC, Stekler JD, Mc-Elrath MJ, Mullins JI. 2011. Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. J Virol 85:7523-7534. http://dx.doi.org/10.1128/JVI.02697-10.
6. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105:7552-7557. http://dx.doi.org/10.1073/pnas.0802203105.
7. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73:10489-10502.
8. Gottlieb GS, Heath L, Nickle DC, Wong KG, Leach SE, Jacobs B, Gezahegne S, van 't Wout AB, Jacobson LP, Margolick JB, Mullins JI. 2008. HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J Infect Dis 197:1011-1015. http://dx.doi.org/10.1086/529206.
9. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650-4655.
10. Liu Y, McNevin J, Cao J, Zhao H, Genowati I, Wong K, McLaughlin S, McSweyn MD, Diem K, Stevens CE, Maenza J, He H, Nickle DC, Shriner D, Holte SE, Collier AC, Corey L, McElrath MJ, Mullins JI. 2006. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol 80:9519-9529. http://dx.doi.org/10.1128/JVI.00575-06.
11. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, Keele BF, Learn GH, Turnbull EL, Salazar MG, Weinhold KJ, Moore S, Letvin N, Haynes BF, Cohen MS, Hraber P, Bhattacharya T, Borrow P, Perelson AS, Hahn BH, Shaw GM, Korber BT, McMichael AJ. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206: 1253-1272. http://dx.doi.org/10.1084/jem.20090365.
12. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, Macalalad AR, Berlin AM, Malboeuf CM, Ryan EM, Gnerre S, Zody MC, Erlich RL, Green LM, Berical A, Wang Y, Casali M, Streeck H, Bloom AK, Dudek T, Tully D, Newman R, Axten KL, Gladden AD, Battis L, Kemper M, Zeng Q, Shea TP, Gujja S, Zedlack C, Gasser O, Brander C, Hess C, Gunthard HF, Brumme ZL, Brumme CJ, Bazner S, Rychert J, Tinsley JP, Mayer KH, Rosenberg E, Pereyra F, Levin JZ, Young SK, Jessen H, Altfeld M, Birren BW, Walker BD, Allen TM. 2012. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog 8:e1002529. http://dx.doi.org/10.1371/journal.ppat.1002529.
13. Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, Abraha A, Tebit DM, Zhao H, Avila S, Lobritz MA, McElrath MJ, Le Gall S, Mullins JI, Arts EJ. 2009. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog 5:e1000365. http://dx.doi.org/10.1371/journal.ppat.1000365.
14. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJ. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10:282-289. http://dx.doi.org/10.1038/nm992.
15. Rolland M, Heckerman D, Deng W, Rousseau CM, Coovadia H, Bishop K, Goulder PJ, Walker BD, Brander C, Mullins JI. 2008. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One 3:e1424. http://dx.doi.org/10.1371/journal.pone.0001424.
16. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, Reddy S, de Pierres C, Mncube Z, Mkhwanazi N, Bishop K, van der Stok M, Nair K, Khan N, Crawford H, Payne R, Leslie A, Prado J, Prendergast A, Frater J, McCarthy N, Brander C, Learn GH, Nickle D, Rousseau C, Coovadia H, Mullins JI, Heckerman D, Walker BD, Goulder P. 2007. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13:46-53. http://dx.doi.org/10.1038/nm1520.
17. Masemola A, Mashishi T, Khoury G, Mohube P, Mokgotho P, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM. 2004. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol 78: 3233-3243. http://dx.doi.org/10.1128/JVI.78.7.3233-3243.2004.
18. Zuñiga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, Hernandez A, Sanchez H, Frahm N, Linde CH, Hewitt HS, Hildebrand W, Altfeld M, Allen TM, Walker BD, Korber BT, Leitner T, Sanchez J, Brander C. 2006. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 80:3122-3125. http://dx.doi.org/10.1128/JVI.80.6.3122-3125.2006.
19. Ganusov VV, Goonetilleke N, Liu MK, Ferrari G, Shaw GM, McMichael AJ, Borrow P, Korber BT, Perelson AS. 2011. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection. J Virol 85: 10518-10528. http://dx.doi.org/10.1128/JVI.00655-11.
20. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay T, Rousseau C, Mullins JI, Brander C, Walker BD, Stuart DI, Kiepiela P, Goulder P. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 80: 3617-3623. http://dx.doi.org/10.1128/JVI.80.7.3617-3623.2006.
21. Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, Cullen C, Evans DT, Desrosiers RC, Mothe BR, Sidney J, Sette A, Kunstman K, Wolinsky S, Piatak M, Lifson J, Hughes AL, Wilson N, O'Connor DH, Watkins DI. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med 10:275-281. http://dx.doi.org/10.1038/nm998.
22. Liu Y, McNevin J, Zhao H, Tebit DM, Troyer RM, McSweyn M, Ghosh AK, Shriner D, Arts EJ, McElrath MJ, Mullins JI. 2007. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. J Virol 81:12179-12188. http://dx.doi.org/10.1128/JVI.01277-07.
23. Boutwell CL, Carlson JM, Lin TH, Seese A, Power KA, Peng J, Tang Y, Brumme ZL, Heckerman D, Schneidewind A, Allen TM. 2013. Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins. J Virol 87:3952-3965. http://dx.doi.org/10.1128/JVI.03233-12.
24. Rolland MMS, Swain JV, Lanxon-Cookson EC, Kim M, Westfall DH, Larsen BB, Gilbert PB, Mullins JI. 2013. HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity. J Virol 87:5461-5467. http://dx.doi.org/10.1128/JVI.03033-12.
25. Manocheewa S, Swain JV, Lanxon-Cookson E, Rolland M, Mullins JI. 2013. Fitness costs of mutations at the HIV-1 capsid hexamerization interface. PLoS One 8:e66065. http://dx.doi.org/10.1371/journal.pone.0066065.
26. Rihn SJ, Wilson SJ, Loman NJ, Alim M, Bakker SE, Bhella D, Gifford RJ, Rixon FJ, Bieniasz PD. 2013. Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog 9:e1003461. http://dx.doi.org/10.1371/journal.ppat.1003461.
27. Brockman MA, Schneidewind A, Lahaie M, Schmidt A, Miura T, Desouza I, Ryvkin F, Derdeyn CA, Allen S, Hunter E, Mulenga J, Goepfert PA, Walker BD, Allen TM. 2007. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A J Virol 81:12608-12618.
28. Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, Block BL, Brumme ZL, Brumme CJ, Baker B, Rothchild AC, Li B, Trocha A, Cutrell E, Frahm N, Brander C, Toth I, Arts EJ, Allen TM, Walker BD. 2009. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J Virol 83:2743-2755. http://dx.doi.org/10.1128/JVI.02265-08.
29. Schneidewind A, Brockman MA, Sidney J, Wang YE, Chen H, Suscovich TJ, Li B, Adam RI, Allgaier RL, Mothe BR, Kuntzen T, Oniangue-Ndza C, Trocha A, Yu XG, Brander C, Sette A, Walker BD, Allen TM. 2008. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J Virol 82:5594-5605. http://dx.doi.org/10.1128/JVI.02356-07.
30. Liu Y, McNevin JP, Holte S, McElrath MJ, Mullins JI. 2011. Dynamics of viral evolution and CTL responses in HIV-1 infection. PLoS One 6:e15639. http://dx.doi.org/10.1371/journal.pone.0015639.
31. Rolland M, Nickle DC, Mullins JI. 2007. HIV-1 group M conserved elements vaccine. PLoS Pathog 3:e157. http://dx.doi.org/10.1371/journal.ppat.0030157.
32. Schacker T, Collier AC, Hughes J, Shea T, Corey L. 1996. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125: 257-264. http://dx.doi.org/10.7326/0003-4819-125-4-199608150-00001.
33. Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L. 1998. Biological and virologic characteristics of primary HIV infection. Ann Intern Med 128:613-620. http://dx.doi.org/10.7326/0003-4819-128-8-199804150-00001.
34. Stekler J, Sycks BJ, Holte S, Maenza J, Stevens CE, Dragavon J, Collier AC, Coombs RW. 2008. HIV dynamics in seminal plasma during primary HIV infection. AIDS Res Hum Retroviruses 24:1269-1274. http://dx.doi.org/10.1089/aid.2008.0014.
35. Janes H, Friedrich DP, Krambrink A, Smith RJ, Kallas EG, Horton H, Casimiro DR, Carrington M, Geraghty DE, Gilbert PB, McElrath MJ, Frahm N. 2013. Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. J Infect Dis 208:1231-1239. http://dx.doi.org/10.1093/infdis/jit322.
36. Sunshine J, Kim M, Carlson JM, Heckerman D, Czartoski J, Migueles SA, Maenza J, McElrath MJ, Mullins JI, Frahm N. 2014. Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication. J Virol 88:1354-1365. http://dx.doi.org/10.1128/JVI.02361-13.
37. Llano AF, Brander NC. 2009. How to optimally define optimal cytotoxic T lymphocyte epitopes in HIV infection? p 3-24. In Yusim K, Brander C, Haynes BF, Koup R, Moore JP, Watkins DI (ed), HIV molecular immunology. Los Alamos National Laboratory, Theoretical Biology and Biophysics Group, Los Alamos, NM.
38. Frahm N, Adams S, Kiepiela P, Linde CH, Hewitt HS, Lichterfeld M, Sango K, Brown NV, Pae E, Wurcel AG, Altfeld M, Feeney ME, Allen TM, Roach T, St John MA, Daar ES, Rosenberg E, Korber B, Marincola F, Walker BD, Goulder PJ, Brander C. 2005. HLA-B63 presents HLAB57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J Virol 79:10218-10225. http://dx.doi.org/10.1128/JVI.79.16.10218-10225.2005.
39. Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, Huang Y, Spies GA, De Rosa SC, McElrath MJ. 2012. Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J Clin Invest 122:359-367. http://dx.doi.org/10.1172/JCI60202.
40. Larsen BB, Chen L, Maust BS, Kim M, Zhao H, Deng W, Westfall D, Beck I, Frenkel LM, Mullins JI. 2013. Improved detection of rare HIV-1 variants using 454 pyrosequencing. PLoS One 8:e76502. http://dx.doi.org/10.1371/journal.pone.0076502.
41. Deng W, Maust BS, Westfall DH, Chen L, Zhao H, Larsen B, Iyer S, Liu Y, Mullins JI. 2013. Indel and Carryforward Correction (ICC): a new analysis approach for processing 454 pyrosequencing data. Bioinformatics http://dx.doi.org/10.1093/bioinformatics/btt434.
42. van den Ent F, Lowe J. 2006. RF cloning: a restriction-free method for inserting target genes into plasmids. J Biochem Biophys Methods 67:67-74. http://dx.doi.org/10.1016/j.jbbm.2005.12.008.
43. Lanxon-Cookson EC, Swain JV, Manocheewa S, Smith RA, Maust B, Kim M, Westfall D, Rolland M, Mullins JI. 2013. Factors affecting relative fitness measurements in pairwise competition assays of human immunodeficiency viruses. J Virol Methods 194:7-13. http://dx.doi.org/10.1016/j.jviromet.2013.07.062.
44. Reed LJM, H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497.
45. McClure J, van't Wout AB, Tran T, Mittler JE. 2007. Granulocytemonocyte colony-stimulating factor upregulates HIV-1 replication in monocyte-derived macrophages cultured at low density. J Acquir Immune Defic Syndr 44:254-261. http://dx.doi.org/10.1097/QAI.0b013e318030f5c5.
46. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, Johnston MN, Corcoran C, Wurcel AG, Fitzpatrick CA, Feeney ME, Rodriguez WR, Basgoz N, Draenert R, Stone DR, Brander C, Goulder PJR, Rosenberg ES, Altfeld M, Walker BD. 2003. Comprehensive epitope analysis of HIV-1-specific T cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77:2081-2092. http://dx.doi.org/10.1128/JVI.77.3.2081-2092.2003.
47. Nielsen M, Lundegaard C, Lund O, Kesmir C. 2005. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 57: 33-41. http://dx.doi.org/10.1007/s00251-005-0781-7.
48. Kesmir C, Nussbaum AK, Schild H, Detours V, Brunak S. 2002. Prediction of proteasome cleavage motifs by neural networks. Protein Eng 15:287-296. http://dx.doi.org/10.1093/protein/15.4.287.
49. Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, Brander C, Holmes EC, Chang SC, Feeney ME, Addo MM, Ruiz L, Ramduth D, Jeena P, Altfeld M, Thomas S, Tang Y, Verrill CL, Dixon C, Prado JG, Kiepiela P, Martinez-Picado J, Walker BD, Goulder PJ. 2004. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med 199:905-915. http://dx.doi.org/10.1084/jem.20031982.
50. Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, Meier A, Brumme CJ, Rosenberg ES, Alter G, Allen TM, Walker BD, Altfeld M. 2008. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med 5:e100. http://dx.doi.org/10.1371/journal.pmed.0050100.
51. Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J, Hraber P, Hewitt HS, Linde CH, Kavanagh DG, Woodberry T, Henry LM, Faircloth K, Listgarten J, Kadie C, Jojic N, Sango K, Brown NV, Pae E, Zaman MT, Bihl F, Khatri A, John M, Mallal S, Marincola FM, Walker BD, Sette A, Heckerman D, Korber BT, Brander C. 2007. Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur J Immunol 37:2419-2433. http://dx.doi.org/10.1002/eji.200737365.
52. Chukkapalli V, Ono A. 2011. Molecular determinants that regulate plasma membrane association of HIV-1 Gag. J Mol Biol 410:512-524. http://dx.doi.org/10.1016/j.jmb.2011.04.015.
53. Brackenridge S, Evans EJ, Toebes M, Goonetilleke N, Liu MK, di Gleria K, Schumacher TN, Davis SJ, McMichael AJ, Gillespie GM. 2011. An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. J Virol 85:5415-5422. http://dx.doi.org/10.1128/JVI.00238-11.
54. Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hue S, Fletcher AJ, Lee K, KewalRamani VN, Noursadeghi M, Jenner RG, James LC, Bushman FD, Towers GJ. 2011. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog 7:e1002439. http://dx.doi.org/10.1371/journal.ppat.1002439.
55. Boutwell CL, Rowley CF, Essex M. 2009. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. J Virol 83:2460-2468. http://dx.doi.org/10.1128/JVI.01970-08.
56. Song H, Pavlicek JW, Cai F, Bhattacharya T, Li H, Iyer SS, Bar KJ, Decker JM, Goonetilleke N, Liu MK, Berg A, Hora B, Drinker MS, Eudailey J, Pickeral J, Moody MA, Ferrari G, McMichael A, Perelson AS, Shaw GM, Hahn BH, Haynes BF, Gao F. 2012. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome. Retrovirology 9:89. http://dx.doi.org/10.1186/1742-4690-9-89.
57. Dulude D, Berchiche YA, Gendron K, Brakier-Gingras L, Heveker N. 2006. Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1. Virology 345:127-136. http://dx.doi.org/10.1016/j.virol.2005.08.048.
58. Liu S, Jing W, Cheung B, Lu H, Sun J, Yan X, Niu J, Farmar J, Wu S, Jiang S. 2007. HIV gp41 C-terminal heptad repeat contains multifunc-tional domains. Relation to mechanisms of action of anti-HIV peptides. J Biol Chem 282:9612-9620.
59. Sidney J, Peters B, Frahm N, Brander C, Sette A. 2008. HLA class I supertypes: a revised and updated classification. BMC Immunol 9:1. http://dx.doi.org/10.1186/1471-2172-9-1.
60. Li B, Gladden AD, Altfeld M, Kaldor JM, Cooper DA, Kelleher AD, Allen TM. 2007. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J Virol 81:193-201. http://dx.doi.org/10.1128/JVI.01231-06.
61. Fryer HR, Frater J, Duda A, Palmer D, Phillips RE, McLean AR. 2012. Cytotoxic T-lymphocyte escape mutations identified by HLA association favor those which escape and revert rapidly. J Virol 86:8568-8580. http://dx.doi.org/10.1128/JVI.07020-11.
62. Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, Carlson JM, Derdeyn CA, Tang J, Kaslow RA, Bansal A, Yusim K, Heckerman D, Mulenga J, Allen S, Goulder PJ, Hunter E. 2008. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 205:1009-1017. http://dx.doi.org/10.1084/jem.20072457.
63. Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, Swenson LC, Tao I, Szeto S, Rosato P, Sela J, Kadie CM, Frahm N, Brander C, Haas DW, Riddler SA, Haubrich R, Walker BD, Harrigan PR, Heckerman D, Mallal S. 2009. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 4:e6687. http://dx.doi.org/10.1371/journal.pone.0006687.
64. Alexander-Miller MA, Leggatt GR, Berzofsky JA. 1996. Selective expansion of high-or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci U S A 93:4102-4107. http://dx.doi.org/10.1073/pnas.93.9.4102.
65. Derby M, Alexander-Miller M, Tse R, Berzofsky J. 2001. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J Immunol 166:1690-1697. http://dx.doi.org/10.4049/jimmunol.166.3.1690.
66. Mailliard RB, Smith KN, Fecek RJ, Rappocciolo G, Nascimento EJ, Marques ET, Watkins SC, Mullins JI, Rinaldo CR. 2013. Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination. J Immunol 191:2570-2580. http://dx.doi.org/10.4049/jimmunol.1300373.
67. Allen TM, Yu XG, Kalife ET, Reyor LL, Lichterfeld M, John M, Cheng M, Allgaier RL, Mui S, Frahm N, Alter G, Brown NV, Johnston MN, Rosenberg ES, Mallal SA, Brander C, Walker BD, Altfeld M. 2005. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol 79:12952-12960. http://dx.doi.org/10.1128/JVI.79.20.12952-12960.2005.
68. Fischer W, Perkins S, Theiler J, Bhattacharya T, Yusim K, Funkhouser R, Kuiken C, Haynes B, Letvin NL, Walker BD, Hahn BH, Korber BT. 2007. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat Med 13:100-106. http://dx.doi.org/10.1038/nm1461.
69. Nickle DC, Rolland M, Jensen MA, Pond SL, Deng W, Seligman M, Heckerman D, Mullins JI, Jojic N. 2007. Coping with viral diversity in HIV vaccine design. PLoS Comput Biol 3:e75. http://dx.doi.org/10.1371/journal.pcbi.0030075.